Rocuronium
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | ZEMURON | — | 2008-08-28 | fda.gov ↗ |
| Approved | US (FDA) | ZEMURON | — | 1994-03-17 | fda.gov ↗ |
Trials 115 · started per year
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 02 trials | ||||||
| Phase 0 | NCT05619848 | Oct → Dec 2022 | lumbar spinal stenosis | Zheng Guo | Completed | No outcome recorded |
| Phase 0 | NCT05097508 | Jun 2020 → Jun 2021 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 27 trials | ||||||
| Phase 2 | NCT07252921 | Oct → Dec 2025 | — | Jiangsu HengRui Medicine Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT03808077 | Jan 2019 → Oct 2024 overdue | prostate cancer | Memorial Sloan Kettering Cancer Center | Active not recruiting | No outcome recorded |
| Phase 2 | NCT03532178 | Jan 2019 → Mar 2022 | — | University of California, San Francisco | Completed | No outcome recorded |
| Phase 2 | NCT02790164 | May → Nov 2016 | cardiac arrest | Chun Song Youn | Completed | No outcome recorded |
| Phase 2 | NCT02260258 | Oct 2014 → May 2019 | cardiac arrest | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT01571908 | Sep 2012 → Jul 2015 | — | University Hospital, Geneva | Completed | No outcome recorded |
| Phase 2 | NCT03519867 | Aug 2004 → May 2005 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 313 trials | ||||||
| Phase 3 | NCT05725031 | Apr 2023 → Feb 2024 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 3 | NCT04709315 | Oct 2020 → Jan 2021 | — | South Valley University | Unknown | No outcome recorded |
| Phase 3 | NCT03043157 | Feb → Mar 2017 | — | Brasilia University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT02000674 | Dec 2013 → Jul 2016 | — | Centre Hospitalier Universitaire de la Réunion | Completed | No outcome recorded |
| Phase 3 | NCT00656799 | Apr 2008 → Jul 2009 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00559468 | Dec 2006 → Mar 2007 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00474253 | Feb → Aug 2006 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00421148 | May 2005 → May 2006 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00124722 | Dec 2004 → Jul 2007 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00124735 | Oct 2004 → Aug 2007 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00984633 | Jun → Dec 2003 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00988520 | May → Sep 2003 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00970762 | Feb 2003 → Feb 2004 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 441 trials | ||||||
| Phase 4 | NCT07650552 | Sep 2026 → Aug 2028 expected | apnea of prematurity, newborn respiratory distress syndrome, pulmonary immaturity | UEA - Universidade Do Estado Do Amazonas | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07168252 | Dec 2025 → Dec 2026 expected | — | Clare Hayes-Bradley | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT06029049 | Sep 2023 → Jun 2025 overdue | — | The University of Texas Health Science Center, Houston | Recruiting | No outcome recorded |
| Phase 4 | NCT05562999 | Nov 2022 → Aug 2024 | — | Radboud University Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT05509192 | Aug 2022 → Jan 2025 | — | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
| Phase 4 | NCT03643913 | Dec 2018 → Nov 2024 | arthropathy | Universitaire Ziekenhuizen KU Leuven | Completed | No outcome recorded |
| Phase 4 | NCT03572413 | Oct 2018 → Aug 2020 | — | Radboud University Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT03608436 | Oct 2018 → Mar 2021 | — | Radboud University Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT03646266 | Aug 2018 → Dec 2020 | respiratory failure | Amsterdam UMC, location VUmc | Unknown | No outcome recorded |
| Phase 4 | NCT03543826 | May → Nov 2018 | myopathy | University of Washington | Completed | No outcome recorded |
| Phase 4 | NCT03031808 | Oct 2017 → Dec 2020 | — | Ostfold Hospital Trust | Unknown | No outcome recorded |
| Phase 4 | NCT03170661 | Jun 2017 → Apr 2020 | — | Leiden University Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT03039543 | Jun → Nov 2017 | — | Seoul National University Bundang Hospital | Completed | No outcome recorded |
| Phase 4 | NCT03060707 | Mar → Nov 2017 | — | Seoul National University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02812186 | Dec 2016 → Jan 2019 | cholecystitis, chronic kidney disease, endometriosis, intestinal obstruction +3 | Stony Brook University | Completed | No outcome recorded |
| Phase 4 | NCT02778945 | Sep 2016 → Mar 2019 | myopathy, vertebral column disorder | The Catholic University of Korea | Unknown | No outcome recorded |
| Phase 4 | NCT02484651 | Sep 2016 → Jun 2017 | neuromuscular disease | Centro Hospitalar do Porto | Completed | No outcome recorded |
| Phase 4 | NCT02451202 | Jun 2016 → Mar 2018 | — | Chulalongkorn University | Completed | No outcome recorded |
| Phase 4 | NCT02724111 | May 2016 → Feb 2017 | vertebral column disorder | Korea University Guro Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02703909 | May 2016 → May 2017 | morbid obesity | University of Missouri-Columbia | Completed | No outcome recorded |
| Phase 4 | NCT02589691 | Dec 2015 → Dec 2024 | — | Fondation Ophtalmologique Adolphe de Rothschild | Unknown | No outcome recorded |
| Phase 4 | NCT02553629 | Sep 2015 → Apr 2016 | — | Leiden University Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT02410590 | Jul 2015 → Oct 2016 | — | Merck Sharp & Dohme LLC | Withdrawn | No outcome recorded |
| Phase 4 | NCT02513693 | Jul 2015 → Mar 2016 | — | Palacky University | Unknown | No outcome recorded |
| Phase 4 | NCT02467595 | Jul 2015 → Oct 2016 | — | Korea University Anam Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02194855 | Jan 2015 → Jan 2016 | — | Fudan University | Completed | No outcome recorded |
| Phase 4 | NCT01941628 | Aug 2014 → Dec 2016 | — | Charles University, Czech Republic | Completed | No outcome recorded |
| Phase 4 | NCT02237443 | Aug → Nov 2014 | — | University of Washington | Completed | No outcome recorded |
| Phase 4 | NCT02118844 | Jul 2014 → Aug 2015 | morbid obesity | Central Hospital, Nancy, France | Unknown | No outcome recorded |
| Phase 4 | NCT02399397 | Feb 2014 → Dec 2015 | autoinflammatory syndrome, infectious disease with sepsis | São Paulo State University | Completed | No outcome recorded |
| Phase 4 | NCT02004015 | Nov 2013 → Apr 2015 | — | Fondation Ophtalmologique Adolphe de Rothschild | Terminated | No outcome recorded |
| Phase 4 | NCT01748643 | Apr 2013 → Jan 2015 | obesity disorder | Ziekenhuis Oost-Limburg | Completed | No outcome recorded |
| Phase 4 | NCT01930747 | Apr 2013 → Dec 2015 | — | AZ Sint-Jan AV | Completed | No outcome recorded |
| Phase 4 | NCT01728584 | Nov 2012 → Apr 2014 | gallbladder disorder | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 4 | NCT01718236 | Sep 2012 → Jan 2015 | pregnancy disorder | Brno University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01651572 | Jul 2012 → Jul 2013 | curariform drugs toxicity | Azienda Ospedaliera di Padova | Completed | No outcome recorded |
| Phase 4 | NCT01804933 | Jul 2012 → Jul 2013 | — | Ying Xiao | Unknown | No outcome recorded |
| Phase 4 | NCT01579864 | Jan 2012 → Jun 2015 | — | Hopital Foch | Terminated | No outcome recorded |
| Phase 4 | NCT00953550 | Sep 2009 → Jan 2011 | — | Rigshospitalet, Denmark | Completed | No outcome recorded |
| Phase 4 | NCT01142635 | Apr 2009 → Mar 2010 | — | Tampere University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02785653 | Apr 2004 → Nov 2006 | — | Maharashtra University of Health Sciences | Completed | No outcome recorded |
| Phase not applicable52 trials | ||||||
| — | NCT07627750 | Jun 2026 → Dec 2028 expected | — | Bach Mai Hospital | Not yet recruiting | No outcome recorded |
| — | NCT07464288 | Mar → Apr 2026 overdue | — | Ankara City Hospital Bilkent | Not yet recruiting | No outcome recorded |
| — | NCT07035301 | Mar → Jul 2025 | respiratory system disorder | Harbin Medical University | Completed | No outcome recorded |
| — | NCT06553066 | Aug 2024 → Aug 2026 overdue | — | University Hospital of Patras | Not yet recruiting | No outcome recorded |
| — | NCT05909696 | Jul → Oct 2023 | curariform drugs toxicity | Yangzhou University | Completed | No outcome recorded |
| — | NCT05279898 | Feb 2023 → Jun 2024 | delirium | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| — | NCT05453929 | Sep 2021 → Dec 2024 | vertebral column disorder | Korea University Guro Hospital | Completed | No outcome recorded |
| — | NCT04924621 | Jun 2021 → May 2022 | substance withdrawal syndrome | Peking University | Unknown | No outcome recorded |
| — | NCT04821817 | Apr 2021 → Feb 2025 | strabismus | Tanta University | Completed | No outcome recorded |
| — | NCT04768400 | Mar 2021 → May 2022 | brain neoplasm | Gangnam Severance Hospital | Completed | No outcome recorded |
| — | NCT05689957 | Dec 2020 → Dec 2021 | female reproductive system disorder | Universiti Sains Malaysia | Completed | No outcome recorded |
| — | NCT04259112 | Oct 2020 → Oct 2023 | acute kidney injury, diabetes mellitus | Peking Union Medical College Hospital | Unknown | No outcome recorded |
| — | NCT03441828 | Feb → Jul 2020 | — | Federico II University | Completed | No outcome recorded |
| — | NCT03937440 | Jul → Dec 2019 | gastric cancer | Yonsei University | Completed | No outcome recorded |
| — | NCT03287388 | May → Nov 2019 | neuromuscular disease | Radboud University Medical Center | Unknown | No outcome recorded |
| — | NCT03890406 | Apr → Dec 2019 | — | Seoul National University Bundang Hospital | Completed | No outcome recorded |
| — | NCT03871387 | Mar 2019 → Feb 2020 | thyroid tumor | Yonsei University | Completed | No outcome recorded |
| — | NCT03830086 | Feb → Apr 2019 | — | IRCCS Azienda Ospedaliero-Universitaria di Bologna | Completed | No outcome recorded |
| — | NCT03782233 | Jan → Jul 2019 | — | The First Affiliated Hospital with Nanjing Medical University | Completed | No outcome recorded |
| — | NCT03726372 | Nov 2018 → Nov 2019 | — | Air Force Military Medical University, China | Unknown | No outcome recorded |
| — | NCT03576118 | Nov 2018 → Jul 2019 | — | Ajou University School of Medicine | Completed | No outcome recorded |
| — | NCT03266419 | Mar → Nov 2018 | — | Asan Medical Center | Completed | No outcome recorded |
| — | NCT03299621 | Nov 2017 → Aug 2018 | — | Korea University Anam Hospital | Unknown | No outcome recorded |
| — | NCT03270696 | Aug 2017 → Jan 2018 | — | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT03391700 | Aug 2017 → Jul 2018 | pharyngitis | SMG-SNU Boramae Medical Center | Unknown | No outcome recorded |
| — | NCT03424356 | Jan 2017 → Dec 2018 | — | TC Erciyes University | Unknown | No outcome recorded |
| — | NCT02762890 | Oct 2016 → Feb 2017 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT02827435 | Jul 2016 → Jul 2019 | disease related to solid organ transplantation, end stage renal failure | Seoul National University Hospital | Unknown | No outcome recorded |
| — | NCT03318718 | Feb 2016 → Dec 2018 | — | Balgrist University Hospital | Completed | No outcome recorded |
| — | NCT02657187 | Feb → Jul 2016 | — | Go Eun Bae | Unknown | No outcome recorded |
| — | NCT04236050 | Dec 2015 → Aug 2017 | lumbar disk disease | Clinical Hospital Centre Zagreb | Completed | No outcome recorded |
| — | NCT02546843 | Dec 2015 → Sep 2018 | — | Brno University Hospital | Completed | No outcome recorded |
| — | NCT02601508 | Nov 2015 → Aug 2016 | — | Chonnam National University Hospital | Unknown | No outcome recorded |
| — | NCT02575443 | Sep 2015 → Sep 2017 | — | Seoul National University Bundang Hospital | Completed | No outcome recorded |
| — | NCT02711917 | Jul → Dec 2015 | — | Tianjin Medical University General Hospital | Completed | No outcome recorded |
| — | NCT02400931 | Apr → Nov 2015 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT02471521 | Feb → Dec 2015 | — | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT02249585 | Sep 2014 → Oct 2016 | — | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT02266056 | Aug 2014 → Sep 2015 | colorectal cancer | Yonsei University | Completed | No outcome recorded |
| — | NCT02109133 | May → Dec 2014 | — | Yonsei University | Completed | No outcome recorded |
| — | NCT02495038 | Mar 2014 → Feb 2015 | chronic otitis media | Yonsei University | Completed | No outcome recorded |
| — | NCT02064140 | Feb → Nov 2014 | acute respiratory distress syndrome | University Medical Center Nijmegen | Completed | No outcome recorded |
| — | NCT02025075 | Jan 2014 → Oct 2015 | acute lung injury | Massachusetts General Hospital | Completed | No outcome recorded |
| — | NCT01849211 | Apr 2013 → Apr 2017 | — | Kreiskrankenhaus Dormagen | Completed | No outcome recorded |
| — | NCT01672606 | May 2012 → Feb 2016 | obstructive sleep apnea syndrome | Malin Jonsson Fagerlund | Completed | No outcome recorded |
| — | NCT01564576 | Apr → Aug 2012 | morbid obesity | Sheba Medical Center | Unknown | No outcome recorded |
| — | NCT02054468 | Mar 2012 → Feb 2014 | — | Technical University of Munich | Completed | No outcome recorded |
| — | NCT01479751 | Nov 2011 → May 2012 | — | Seoul National University Bundang Hospital | Completed | No outcome recorded |
| — | NCT01441960 | May 2011 → Jul 2013 | — | Massachusetts General Hospital | Completed | No outcome recorded |
| — | NCT01532466 | Mar → Oct 2011 | — | Taichung Armed Forces General Hospital | Completed | No outcome recorded |
| — | NCT04035707 | Jun 2009 → Jun 2010 | hypersensitivity reaction disease | Medical University of Bialystok | Completed | No outcome recorded |
| — | NCT00926718 | Jun 2009 → Jun 2010 | laryngostenosis | St. Vincent's Medical Center | Unknown | No outcome recorded |
Also used as a comparator or background therapy in 178 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 03 trials | ||||||
| Phase 0 | NCT06720285 Background | Oct → Nov 2023 | — | Universitas Airlangga | Completed | No outcome recorded |
| Phase 0 | NCT05294926 Comparator | Apr 2022 → Jan 2023 | — | Assiut University | Unknown | No outcome recorded |
| Phase 0 | NCT04016740 Background | Aug 2019 → Feb 2020 | coronary artery disorder, delirium | Beth Israel Deaconess Medical Center | Completed | No outcome recorded |
| Phase 12 trials | ||||||
| Phase 1 | NCT07603596 Background | May 2026 → Apr 2028 expected | delirium, digestive system neoplasm | Qianfoshan Hospital | Not yet recruiting | No outcome recorded |
| Phase 1 | NCT02888067 Comparator | Jul 2017 → Jul 2022 | — | Thomas Schricker | Terminated | No outcome recorded |
| Phase 211 trials | ||||||
| Phase 2 | NCT07595393 Background | Aug 2026 → Jun 2027 expected | curariform drugs toxicity | Amckaus PTY LTD. | Not yet recruiting | No outcome recorded |
| Phase 2 | NCT07404579 Comparator | Mar → May 2026 | — | Jiangsu HengRui Medicine Co., Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT05687253 Comparator | Oct 2022 → Apr 2023 | — | Baudax Bio | Completed | No outcome recorded |
| Phase 2 | NCT03904550 Comparator | Dec 2019 → Aug 2022 | impaired renal function disease | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
| Phase 2 | NCT03448068 Background | Apr 2018 → Jan 2020 | — | Mayo Clinic | Completed | No outcome recorded |
| Phase 2 | NCT02669368 Comparator | Mar 2015 → Mar 2016 | — | Assiut University | Unknown | No outcome recorded |
| Phase 2 | NCT02469831 Comparator | Oct 2014 → Dec 2015 | gallbladder disorder | Assiut University | Completed | No outcome recorded |
| Phase 2 | NCT01937767 Background | Aug 2013 → Feb 2014 | — | Paion UK Ltd. | Completed | No outcome recorded |
| Phase 2 | NCT00552617 Background | Sep 2005 → Aug 2006 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 2 | NCT00535743 Background | Mar → Jul 2004 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 2 | NCT03519854 Background | Dec 2002 → Jun 2003 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 2/33 trials | ||||||
| Phase 2/3 | NCT03367988 Background | Dec 2018 → Jan 2023 | drug dependence | University of South Florida | Unknown | No outcome recorded |
| Phase 2/3 | NCT02393664 Comparator | Mar 2015 → Oct 2016 | lung neoplasm | National Taiwan University Hospital | Unknown | No outcome recorded |
| Phase 2/3 | NCT02147054 Comparator | May 2014 → Jul 2016 | organophosphate poisoning | University of Edinburgh | Completed | No outcome recorded |
| Phase 317 trials | ||||||
| Phase 3 | NCT07299630 Background | Dec 2025 → May 2026 | — | Ain Shams University | Completed | No outcome recorded |
| Phase 3 | NCT06873906 Comparator | Mar 2025 → Mar 2026 overdue | heart septal defect | Ain Shams University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT05958589 Background | Jan 2022 → Jul 2024 | — | University of Novi Sad | Completed | No outcome recorded |
| Phase 3 | NCT04581395 Comparator | Oct 2020 → Apr 2023 | — | Indiana University | Completed | No outcome recorded |
| Phase 3 | NCT03960801 Comparator | Oct 2019 → Apr 2021 | — | Nantes University Hospital | Completed | No outcome recorded |
| Phase 3 | NCT03825198 Comparator | Aug 2019 → Dec 2023 | neuropathy, painful, peripheral nerve lesion | Dr M. B. Breebaart | Unknown | No outcome recorded |
| Phase 3 | NCT03434678 Background | Jan 2018 → Jul 2024 | malignant pancreatic neoplasm | Memorial Sloan Kettering Cancer Center | Completed | No outcome recorded |
| Phase 3 | NCT03669484 Background | Aug 2017 → May 2018 | — | R-Pharm | Completed | No outcome recorded |
| Phase 3 | NCT02634255 Comparator | Dec 2015 → May 2016 | appendicitis | Diskapi Yildirim Beyazit Education and Research Hospital | Unknown | No outcome recorded |
| Phase 3 | NCT01962298 Comparator | Oct 2013 → Dec 2014 | diaphragm disorder, myopathy | University Hospital, Antwerp | Completed | No outcome recorded |
| Phase 3 | NCT01719770 Comparator | Nov 2010 → Oct 2013 | cardiac arrest, curariform drugs toxicity | Medical University of Vienna | Completed | No outcome recorded |
| Phase 3 | NCT00751179 Comparator | Nov 2008 → Dec 2009 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00724932 Background | Jul 2008 → Apr 2009 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00675792 Background | May → Sep 2008 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00473694 Background | Nov 2005 → Nov 2006 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00475215 Background | Oct 2005 → Aug 2006 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 3 | NCT00298831 Background | Oct 2005 → May 2006 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 473 trials | ||||||
| Phase 4 | NCT06564857 Comparator | Nov 2025 → Apr 2027 expected | — | Nordsjaellands Hospital | Recruiting | No outcome recorded |
| Phase 4 | NCT07203287 Comparator | Aug 2025 → Dec 2026 expected | — | The University of Texas Medical Branch, Galveston | Recruiting | No outcome recorded |
| Phase 4 | NCT07044193 Comparator | Jun 2025 → Dec 2028 expected | curariform drugs toxicity | Tamas Vegh, MD | Not yet recruiting | No outcome recorded |
| Phase 4 | NCT07044180 Comparator | Jun 2025 → Dec 2028 expected | curariform drugs toxicity | Tamas Vegh, MD | Active not recruiting | No outcome recorded |
| Phase 4 | NCT06399445 Comparator | Apr 2024 → Jun 2025 | — | University Hospital of Split | Unknown | No outcome recorded |
| Phase 4 | NCT06225466 Comparator | Apr → Sep 2024 | — | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT05887375 Background | Aug 2023 → Jan 2026 | urinary tract obstruction | University of Missouri-Columbia | Completed | No outcome recorded |
| Phase 4 | NCT05602519 Comparator | Nov 2022 → May 2023 | — | Al-Azhar University | Completed | No outcome recorded |
| Phase 4 | NCT05172739 Comparator | Oct 2021 → Nov 2025 overdue | chronic pain syndrome, non-small cell lung carcinoma, substance-related disorder | University of Crete | Recruiting | No outcome recorded |
| Phase 4 | NCT04868409 Comparator | Aug 2021 → Mar 2024 | — | Matias Vested | Completed | No outcome recorded |
| Phase 4 | NCT04802122 Comparator | May → Jul 2021 | — | Aristotle University Of Thessaloniki | Completed | No outcome recorded |
| Phase 4 | NCT04872881 Comparator | May → Aug 2021 | tracheal disorder | Bozyaka Training and Research Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT05468671 Background | Jan → Aug 2021 | bronchial neoplasm | Zhejiang Cancer Hospital | Completed | No outcome recorded |
| Phase 4 | NCT04281017 Background | Nov 2020 → Jun 2026 overdue | — | University of Florida | Recruiting | No outcome recorded |
| Phase 4 | NCT04894864 Comparator | Oct 2020 → Sep 2026 expected | abdominal aortic aneurysm | University of Crete | Recruiting | No outcome recorded |
| Phase 4 | NCT04760912 Comparator | Apr 2020 → Aug 2022 | myopathy | Clinical Hospital Centre Zagreb | Completed | No outcome recorded |
| Phase 4 | NCT04287426 Comparator | Mar → Dec 2020 | — | Rigshospitalet, Denmark | Completed | No outcome recorded |
| Phase 4 | NCT02902055 Comparator | Dec 2019 → May 2024 | pediatric acute respiratory distress syndrome | University Medical Center Groningen | Terminated | No outcome recorded |
| Phase 4 | NCT03962725 Comparator | Aug 2019 → Dec 2022 | aspiration pneumonia, bronchial disorder, pneumonitis, respiratory failure +1 | Beth Israel Deaconess Medical Center | Terminated | No outcome recorded |
| Phase 4 | NCT03910998 Comparator | May 2019 → Jul 2022 | — | Ciusss de L'Est de l'Île de Montréal | Unknown | No outcome recorded |
| Phase 4 | NCT03958201 Background | May 2019 → Jan 2020 | respiratory paralysis | University of Washington | Completed | No outcome recorded |
| Phase 4 | NCT03939923 Comparator | May 2019 → Jul 2021 | coronary artery disorder | West Virginia University | Completed | No outcome recorded |
| Phase 4 | NCT03946657 Comparator | Jan → Jun 2019 | morbid obesity | Ondokuz Mayıs University | Completed | No outcome recorded |
| Phase 4 | NCT03408340 Comparator | Jul 2018 → Jul 2020 | congenital heart disease | Emory University | Terminated | No outcome recorded |
| Phase 4 | NCT03263117 Comparator | Jul 2018 → Apr 2023 | stroke disorder | The University of Texas Health Science Center, Houston | Completed | No outcome recorded |
| Phase 4 | NCT03591289 Comparator | Feb 2018 | female reproductive system disorder, urinary system disorder | Rainer Lenhardt | Withdrawn | No outcome recorded |
| Phase 4 | NCT03346070 Background | Jan 2018 → Jan 2019 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 4 | NCT03346057 Background | Dec 2017 → Sep 2019 | — | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
| Phase 4 | NCT03369782 Comparator | Dec 2017 → Apr 2018 | — | Algemeen Ziekenhuis Maria Middelares | Withdrawn | No outcome recorded |
| Phase 4 | NCT03138967 Background | Sep 2017 → Sep 2018 | urinary bladder cancer | M.D. Anderson Cancer Center | Completed | No outcome recorded |
| Phase 4 | NCT03226080 Comparator | Jul 2017 → Aug 2019 | bone disorder | Loyola University | Withdrawn | No outcome recorded |
| Phase 4 | NCT03176758 Comparator | Jun 2017 → Jun 2018 | — | Meir Medical Center | Unknown | No outcome recorded |
| Phase 4 | NCT03063255 Comparator | Apr 2017 → Sep 2019 | urinary bladder cancer | University of Florida | Completed | No outcome recorded |
| Phase 4 | NCT03881423 Comparator | Apr 2017 → Apr 2019 | — | Wahba bakhet | Completed | No outcome recorded |
| Phase 4 | NCT03135795 Background | Feb → May 2017 | — | Huazhong University of Science and Technology | Unknown | No outcome recorded |
| Phase 4 | NCT04105764 Comparator | Dec 2016 → Nov 2018 | — | Wahba bakhet | Completed | No outcome recorded |
| Phase 4 | NCT02953210 Background | Nov 2016 | neuropathy, painful, paralytic ileus | Federal University of São Paulo | Unknown | No outcome recorded |
| Phase 4 | NCT03540030 Comparator | Sep 2016 → Mar 2019 | avascular necrosis, osteoarthritis, rotator cuff syndrome, substance-related disorder | OrthoCarolina Research Institute, Inc. | Completed | No outcome recorded |
| Phase 4 | NCT02794714 Comparator | Jun 2016 → Dec 2017 | — | Kuala Lumpur General Hospital | Withdrawn | No outcome recorded |
| Phase 4 | NCT02769325 Background | May 2016 → May 2017 | — | Clinica Santa Maria | Unknown | No outcome recorded |
| Phase 4 | NCT05919732 Comparator | Mar 2016 → Mar 2018 | — | Nemours Children's Clinic | Completed | No outcome recorded |
| Phase 4 | NCT02648503 Background | Mar → Sep 2016 | neuromuscular disease | University of Medicine and Pharmacy at Ho Chi Minh City | Unknown | No outcome recorded |
| Phase 4 | NCT02709473 Comparator | Mar 2016 | — | Ankara University | Completed | No outcome recorded |
| Phase 4 | NCT02646709 Background | Jan → May 2016 | hernia, double inguinal | Ajou University School of Medicine | Unknown | No outcome recorded |
| Phase 4 | NCT02642367 Background | Jan → May 2016 | — | Ajou University School of Medicine | Completed | No outcome recorded |
| Phase 4 | NCT02644980 Background | Dec 2015 → Aug 2016 | delirium | Xijing Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02586441 Background | Nov 2015 → Nov 2016 | — | Korea University Anam Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02518789 Background | Sep 2015 → Aug 2016 | — | Tang-Du Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02464722 Background | Aug → Nov 2015 | — | Korea University Anam Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02247466 Comparator | Feb 2015 → Feb 2017 | — | Herlev Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02320734 Comparator | Feb 2015 → Sep 2016 | esophageal cancer, neuromuscular disease | Academic Medical Center - University of Amsterdam | Completed | No outcome recorded |
| Phase 4 | NCT02414880 Comparator | Dec 2014 → Aug 2015 | cirrhosis of liver | Cairo University | Completed | No outcome recorded |
| Phase 4 | NCT02698969 Background | Nov 2014 → Feb 2017 | curariform drugs toxicity | University of Florence | Unknown | No outcome recorded |
| Phase 4 | NCT02140593 Comparator | Sep 2014 → May 2016 | digestive system cancer | Herlev Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02134093 Background | Jul 2014 → May 2015 | — | Tang-Du Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02185339 Comparator | Jul 2014 → Jan 2015 | — | Seoul St. Mary's Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02141737 Background | May → Oct 2014 | — | Tang-Du Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT02036827 Comparator | Dec 2013 → Jan 2015 | — | Yonsei University | Completed | No outcome recorded |
| Phase 4 | NCT02079337 Comparator | Nov 2013 → Apr 2014 | — | Herlev Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01933425 Comparator | Aug 2013 → Apr 2014 | — | Herlev Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01824758 Background | Mar → Apr 2013 | — | Ankara Diskapi Training and Research Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01722097 Comparator | Nov 2012 → Mar 2014 | — | Herlev Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01690338 Comparator | Oct 2012 → Oct 2014 | curariform drugs toxicity | Peking University First Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT01631149 Comparator | Jun 2012 → Mar 2013 | benign prostatic hyperplasia, kidney disorder | Leiden University Medical Center | Completed | No outcome recorded |
| Phase 4 | NCT01523886 Comparator | Mar → Nov 2012 | — | Herlev Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01749501 Comparator | Jan 2011 → Dec 2013 | newborn respiratory distress syndrome | Martin Espinosa, MD | Completed | No outcome recorded |
| Phase 4 | NCT01199237 Comparator | Aug 2010 → Aug 2012 | — | University of California, San Francisco | Completed | No outcome recorded |
| Phase 4 | NCT01518608 Background | Sep 2009 → Sep 2011 | — | Oslo University Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01474252 Background | Jul 2008 → Dec 2012 | — | Siriraj Hospital | Completed | No outcome recorded |
| Phase 4 | NCT02631135 Comparator | Jan → Oct 2008 | — | Uludag University | Completed | No outcome recorded |
| Phase 4 | NCT00540085 Comparator | Oct 2007 → Feb 2008 | — | Rigshospitalet, Denmark | Completed | No outcome recorded |
| Phase 4 | NCT00527332 Comparator | Mar 2007 → Jun 2009 | — | Preben Kjolhede | Completed | No outcome recorded |
| Phase 4 | NCT00355368 Comparator | Aug 2006 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| Phase not applicable69 trials | ||||||
| — | NCT07486336 Comparator | Sep 2026 → Sep 2028 expected | cognitive disorder | Ente Ospedaliero Ospedali Galliera | Not yet recruiting | No outcome recorded |
| — | NCT07680400 Comparator | Jul → Aug 2026 overdue | — | Bezmialem Vakif University | Not yet recruiting | No outcome recorded |
| — | NCT07485517 Comparator | Jun → Dec 2026 expected | — | Menoufia University | Not yet recruiting | No outcome recorded |
| — | NCT07271472 Background | Dec 2025 → May 2026 | — | Ataturk University | Completed | No outcome recorded |
| — | NCT07192549 Background | Sep 2025 → Sep 2030 expected | delirium | General Hospital of Ningxia Medical University | Not yet recruiting | No outcome recorded |
| — | NCT07092046 Comparator | Aug 2025 | — | Ankara City Hospital Bilkent | Completed | No outcome recorded |
| — | NCT06990763 Background | Jun → Dec 2025 overdue | female reproductive system disorder | Second Hospital of Shanxi Medical University | Not yet recruiting | No outcome recorded |
| — | NCT06775366 Background | Feb 2025 → Apr 2026 overdue | circadian rhythm sleep disorder, cognitive disorder | The Second Affiliated Hospital of Chongqing Medical University | Not yet recruiting | No outcome recorded |
| — | NCT06679569 Comparator | Nov 2024 → Nov 2026 expected | — | Seoul National University Hospital | Recruiting | No outcome recorded |
| — | NCT06584695 Comparator | Sep 2024 → Dec 2025 overdue | nephroma | Cairo University | Recruiting | No outcome recorded |
| — | NCT06493396 Background | Aug 2024 → Aug 2025 overdue | sleep disorder | Beijing Friendship Hospital | Not yet recruiting | No outcome recorded |
| — | NCT06707532 Comparator | Aug 2024 → Dec 2025 overdue | acute kidney injury, butyrylcholinesterase deficiency, cardiac rhythm disease, drug-induced myopathy | 4th Military Clinical Hospital with Polyclinic, Poland | Recruiting | No outcome recorded |
| — | NCT06305221 Background | Mar 2024 → Mar 2025 | postgastrectomy syndrome | Beijing Friendship Hospital | Unknown | No outcome recorded |
| — | NCT07568938 Comparator | Jan 2024 → Feb 2027 expected | obesity disorder, substance-related disorder | G.Gennimatas General Hospital | Recruiting | No outcome recorded |
| — | NCT06150001 Comparator | Dec 2023 → Jul 2024 | — | Chang Gung Memorial Hospital | Completed | No outcome recorded |
| — | NCT06120439 Background | Dec 2023 → May 2024 | breast cancer | Jun Zhang | Completed | No outcome recorded |
| — | NCT07337135 Background | Oct 2023 → Apr 2024 | morbid obesity | Hospital dos Lusíadas | Completed | No outcome recorded |
| — | NCT06892600 Comparator | Aug → Oct 2023 | — | Indonesia University | Completed | No outcome recorded |
| — | NCT05872451 Background | Jul 2023 → Apr 2024 | urinary bladder neoplasm | Chosun University Hospital | Completed | No outcome recorded |
| — | NCT07064408 Background | Jun 2023 → Nov 2024 | — | Hebei Medical University Fourth Hospital | Completed | No outcome recorded |
| — | NCT05614609 Comparator | Mar 2023 → Oct 2024 | — | Ostfold University College | Completed | No outcome recorded |
| — | NCT05577962 Background | Feb → Sep 2023 | — | Beijing Friendship Hospital | Unknown | No outcome recorded |
| — | NCT05485480 Comparator | Nov 2022 → Feb 2024 | — | University Hospital, Basel, Switzerland | Completed | No outcome recorded |
| — | NCT05596227 Comparator | Oct 2022 → Sep 2024 | vertebral column disorder | Tanta University | Completed | No outcome recorded |
| — | NCT05543109 Comparator | Sep 2022 → Feb 2023 | developmental dysplasia of the hip, neuropathy, painful | Tanta University | Unknown | No outcome recorded |
| — | NCT05423951 Background | Jul 2022 → Nov 2023 | — | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT06958913 Comparator | May → Nov 2022 | — | Pamukkale University | Completed | No outcome recorded |
| — | NCT03239236 Background | Feb 2021 | — | Medical University of Vienna | Withdrawn | No outcome recorded |
| — | NCT07370779 Comparator | Jan → Oct 2021 | — | Dr. Lutfi Kirdar Kartal Training and Research Hospital | Completed | No outcome recorded |
| — | NCT04512313 Comparator | Dec 2020 → May 2021 | curariform drugs toxicity | Rigshospitalet, Denmark | Completed | No outcome recorded |
| — | NCT04553536 Background | Nov 2020 → Jun 2023 | poisoning | Second Hospital of Shanxi Medical University | Unknown | No outcome recorded |
| — | NCT04595591 Comparator | Oct 2020 → Mar 2021 | — | SanQing Jin | Completed | No outcome recorded |
| — | NCT04294537 Background | Mar → Apr 2020 | appendicitis | Ospedale di Circolo - Fondazione Macchi | Unknown | No outcome recorded |
| — | NCT05417529 Background | Mar 2020 | oral cavity carcinoma | Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari | Completed | No outcome recorded |
| — | NCT04063046 Comparator | Nov 2019 → Jul 2021 | — | Yonsei University | Unknown | No outcome recorded |
| — | NCT03791801 Comparator | Sep 2019 → Dec 2020 | — | McGill University Health Centre/Research Institute of the McGill University Health Centre | Unknown | No outcome recorded |
| — | NCT03910504 Comparator | Apr → Dec 2019 | thyroid gland disorder | Federico Longhini | Completed | No outcome recorded |
| — | NCT03795259 Comparator | Dec 2018 → May 2019 | — | Istanbul University | Completed | No outcome recorded |
| — | NCT03658057 Comparator | Aug → Nov 2018 | — | Seoul National University Hospital | Completed | No outcome recorded |
| — | NCT03602469 Background | Jul → Dec 2018 | — | Mansoura University | Unknown | No outcome recorded |
| — | NCT03009877 Background | Jul 2018 → May 2019 | morbid obesity | Montefiore Medical Center | Withdrawn | No outcome recorded |
| — | NCT03529201 Background | May 2018 → Feb 2019 | chronic pain syndrome, neuropathy, painful | Medical University of Lublin | Completed | No outcome recorded |
| — | NCT03487003 Comparator | Apr 2018 → Jul 2019 | — | Daegu Catholic University Medical Center | Completed | No outcome recorded |
| — | NCT04510337 Comparator | Apr 2018 → Feb 2021 | — | National Cancer Institute, Egypt | Completed | No outcome recorded |
| — | NCT03596060 Comparator | Oct 2017 → May 2022 | — | Larissa University Hospital | Unknown | No outcome recorded |
| — | NCT03447691 Comparator | Aug 2017 → Aug 2022 | digestive system carcinoma | Yonsei University | Unknown | No outcome recorded |
| — | NCT03157479 Background | May 2017 → Mar 2019 | — | Catholic University of the Sacred Heart | Completed | No outcome recorded |
| — | NCT02696837 Comparator | Mar → May 2016 | — | Maltepe University | Completed | No outcome recorded |
| — | NCT01996358 Comparator | Aug 2015 → Dec 2017 | — | Dr. Horst Schmidt Klinik GmbH | Suspended | No outcome recorded |
| — | NCT07033442 Comparator | Jul → Nov 2015 | ocular hypertension | Ataturk Training and Research Hospital | Completed | No outcome recorded |
| — | NCT02318810 Comparator | Mar 2015 → May 2016 | — | University of Rostock | Completed | No outcome recorded |
| — | NCT02880787 Background | Nov 2014 → Dec 2016 | curariform drugs toxicity | Central Hospital, Nancy, France | Unknown | No outcome recorded |
| — | NCT02289586 Comparator | Jul 2014 → Feb 2016 | — | Futian People's Hospital | Unknown | No outcome recorded |
| — | NCT02539706 Comparator | Jan 2014 → Sep 2015 | dysmenorrhea | Aydin Adnan Menderes University | Completed | No outcome recorded |
| — | NCT01851005 Background | May 2013 → Feb 2014 | — | Chosun University Hospital | Completed | No outcome recorded |
| — | NCT03013036 Background | Feb 2013 → Dec 2017 | — | Istanbul University | Unknown | No outcome recorded |
| — | NCT02486926 Background | Nov 2012 → Jul 2013 | — | Hallym University Medical Center | Completed | No outcome recorded |
| — | NCT02109510 Comparator | Nov 2012 → Sep 2013 | pneumothorax | Korea University | Completed | No outcome recorded |
| — | NCT01566838 Comparator | Oct 2012 → Dec 2015 | — | Inova Health Care Services | Completed | No outcome recorded |
| — | NCT01683006 Comparator | Apr 2012 → May 2014 | cardiac arrest | Medical University of Vienna | Completed | No outcome recorded |
| — | NCT01591031 Comparator | Apr 2012 → Feb 2013 | — | University of Rostock | Completed | No outcome recorded |
| — | NCT01550354 Comparator | Feb 2012 → Jan 2014 | ankyloglossia | Yonsei University | Completed | No outcome recorded |
| — | NCT01511627 Comparator | Jan → Jul 2012 | — | University of Saskatchewan | Withdrawn | No outcome recorded |
| — | NCT01902641 Comparator | Oct 2011 → Mar 2012 | pharyngitis | Dr. Horst Schmidt Klinik GmbH | Completed | No outcome recorded |
| — | NCT01389791 Comparator | May 2011 → Jan 2012 | — | Seoul National University Bundang Hospital | Unknown | No outcome recorded |
| — | NCT01436799 Background | Mar → Aug 2011 | brain ischemia | Gachon University Gil Medical Center | Completed | No outcome recorded |
| — | NCT01030510 Comparator | Dec 2009 → Oct 2010 | — | Seoul National University Bundang Hospital | Completed | No outcome recorded |
| — | NCT01035021 Comparator | Jun 2009 → Apr 2010 | breast disorder | Seoul National University Bundang Hospital | Completed | No outcome recorded |
| — | NCT01450813 Comparator | Jun 2009 → Dec 2013 | — | Medtronic - MITG | Completed | No outcome recorded |
Evidence & citations 20 cited values
Every value below carries the sentence it was read from. 296 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rocuronium | “Rocuronium and cisatracurium are representative neuromuscular blocking agents used widely because the former have features of fast onset of peak effect and short duration of...” NCT02495038 ↗263“When participants reach the titration endpoint (OAAS score 1 point) during the titration of propofol in the induction, the investigators stop the dosing and switch to a...” NCT04595591 ↗ “Maintenance of anesthesia will be achieved by isoflurane at an end tidal concentration of 1-1.5% in FiO2 of 0.5, intravenous fentanyl at a dose of 1 µg/kg in incremental...” NCT06873906 ↗ “1-3 mg IV propofol 0.5 mg/kg IV Rocuronium + Fentanyl 2-3 mcg/kg + Morphine 0.1mg/kg IV Maintenance: Volatile anesthetic + High volume local anesthesia infiltration Bupivacaine...” NCT03176758 ↗ “The investigators therefore hypothesized that remifentanil could prolong the onset time of rocuronium, and evaluated the effect of remifentanil on the hemodynamic profiles...” NCT01030510 ↗ “Anesthetized patients (American Society of Anesthesiologists class 1-2) received 0.6 mg/kg rocuronium and were randomized to receive sugammadex (0.5, 1.0, 2.0, or 4.0 mg/kg) or...” PMID 19194156 ↗ Feb 2009 “Remimazolam 6mg/kg/h was pumped intravenously for 2.5 min, Sufentanil 0.5 μg/kg and rocuronium 0.6mg/kg were injected intravenously, and endotracheal intubation was performed 3...” NCT06775366 ↗ “Midazolam 0.03 mg/kg injection vein,Sufentanyl 0.5\~1 μg/kg, target controlled infusion of etomidate or propofol,after the consciousness of patients is lost, rocuronium...” NCT02644980 ↗ “Deep neuromuscular block will be induced by rocuronium bolus 1 mg/kg, maintained by a continuous infusion of rocuronium (0.6mg/kg/h), and titrated towards post-tetanic count (PTC) 1-2.” NCT04259112 ↗ “In addition to propofol as a hypnotic and rocuronium as a muscle relaxant, patients in the conventional opioid-based group will receive the following drugs: Remifentanil and Fentanyl” NCT05485480 ↗ “General anesthesia will be induced with fentanyl 1,5 mcg/kg, propofol 2 mg/kg, rocuronium 0,6 mg/kg; after intubation anesthesia will be mantained with sevoflurane (MAC 1).” NCT04294537 ↗ “Propofol 1,5mg/Kg, supplemented by fentanyl 2mcg/Kg and rocuronium 0,5mg/Kg and O2 100% will be for induction to anesthesia and facilitate endotracheal intubation. .” NCT04802122 ↗ “Rocuronium will be maintained in a arm 1) deep neuromuscular block group or arm 2) moderate neuromuscular block group (control group) according to the assignment.” NCT03937440 ↗ “Induction agents will be administered as quick boluses (Propofol 2,5mg/kg total body weight, max 350mg, Fentanyl 250mcg, Rocuronium 1,2mg/kg ideal body weight).” NCT03239236 ↗ “Anesthetic agents, including propofol, fentanyl, rocuronium, and sevoflurane, were used as part of standard anesthetic management during the procedure.” NCT07370779 ↗ “General anesthesia induction will be performed with fentanyl 1-2 μg/kg, propofol 2-3 mg/kg, and rocuronium 0.6 mg/kg and maintained with sevoflurane.” NCT06584695 ↗ “Induction with 1% propofol (2-3 mg/kg), fentanyl (1-3 mg/kg), and Rocuronium 1-1.5 mg/kg. Before the injection of propofol, 5 mL 1% lidocaine (50 mg)” NCT04281017 ↗ “Standardized general anaesthesia with fentanyl 2 mcg/kg ABW at induction, propofol 1.5 mg/kg, rocuronium 0.6 mg/kg, sevoflurane 1 MAC for maintenance” NCT07299630 ↗ “Patients assigned to MTPI will then be given rocuronium (0.6mg/kg), followed by propofol intravenously as a single bolus within 10 seconds.” NCT05509192 ↗ “Rocuronium 0.3 mg kg-1 was injected at I.V. line to patients (R 0.3 group), as muscle relaxants during anesthesia for adenotonsillectomy.” NCT02467595 ↗ “To maintain TOF at 2 and according to our practice a bolus injection of 0,1 mg/kg Rocuronium will be given when TOF count returns to 3.” NCT03643913 ↗ “The first one included DNMB with a rocuronium bolus at the starting dose of 1.2 mg/kg and a maintenance dose (0.3-0.6 mg/kg/h).” PMID 37386582 ↗ Jan 2023 “Remimazolam, sufentanil and rocuronium were used during induction, and remimazolam and refentanil were used during maintenance” NCT06990763 ↗ “Induction was carried out by fentanyl 3mcg/kg, propofol 2 mg/kg and rocuronium at the dose of 1mg/kg to facilitate intubation” NCT05417529 ↗ “Anaesthesia induction will be obtained with i.v. 2-3 mg/kg propofol, 0,6-0,8 mcg/kg fentanyl, and 0.9-1,2 mg/kg rocuronium.” NCT03157479 ↗ “Anesthesia induction will include 2 mg midazolam, 2-2.5 mg/kg propofol, 0.6-0.9 mg/kg rocuronium, and 1 μg/kg remifentanil.” NCT07271472 ↗ “Deep neuromuscular block will be achieved with high dose rocuronium to achieve a depth of 1-2 twitches post tetanic count” NCT03170661 ↗ “Anesthesia induction with rocuronium 0.4mg/kg and maintenance with rocuronium 0.15mg/kg to maintain TOF 1-2 twitch” NCT02249585 ↗ “Rocuronium will be used for muscle relaxation in order to achieve the necessary depth of neuromuscular blockade.” NCT02794714 ↗ “Intubation is performed 3 minutes after administration of remifentanil 1-2 mcg / kg and rocuronium 0.6 mg / kg.” NCT03447691 ↗ “anaesthesia will be induced with 1.5-2.5 mg/kg propofol, 0.3-0.5 mg/kg esketamine, and 0.6-1.0 mg/kg rocuronium” NCT07603596 ↗ “muscle paralysis may be achieved with succinylcholine or non-depolarizing paralytic (rocuronium or vecuronium)” NCT03263117 ↗ “patients in group C will receive fentanyl 1 μg/kg, propofol 2.5 mg/kg, and rocuronium 0.3 mg/kg intravenously” NCT07680400 ↗ “All patients were induced with individual intravenous doses of midazolam, rocuronium, fentanyl and propofol.” NCT02399397 ↗ “lidocaine (1mg/kg), esketamine (0.5mg/kg), propofol (1-2mg/kg) and rocuronium (0.6mg/kg) were infused slowly” NCT05577962 ↗ “In this case the use of another neuromuscular blockade, Rocuronium (ESMERON), is an alternative solution.” NCT03960801 ↗ “Patients in this group receive 0.06mg/kg of rocuronium before administration of 0.54mg/kg of rocuronium.” NCT01389791 ↗ “Anesthesia was induced by sequential intravenous injection of remimazolam, sufentanil, and rocuronium.” NCT07192549 ↗ “General anesthesia with Lidocaine 1.5mg/kg, Fentanyl 2 mcg/kg, propofol 2 mg/kg, Rocuronium 0.6 mg/kg” NCT06892600 ↗ “standard care group which uses Rocuronium (NMBA) as an adjunct for maintenance of general anesthesia” NCT03962725 ↗ “Anesthesia will be induced with rocuronium 1mg, propofol 3-6 mg/kg, and succinylcholine 1.5 mg/kg” NCT03367988 ↗ “General anesthesia using classical GABAergic-drugs such as propofol, remifentanil and rocuronium.” NCT07486336 ↗ “Continuous Rocuronium (Rocnium®, Hanlim Pharm. Co., Ltd., South Korea) infusion during surgery” NCT03871387 ↗ “Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation in Adults” NCT07252921 ↗ “Rocuronium dose will be infused to maintain a depth of NMB to PTC 1\~2 intraoperatively” NCT01804933 ↗ “rocuronium will be given as 0.2 mg/kg to maintain a post-tetanic count (PTC) of \>1” NCT07485517 ↗ “neuromuscular blockade will be performed using a continuous infusion of rocuronium.” NCT02762890 ↗ “Neuromuscular blockade was performed during the operation by rocuronium infusion” NCT03946657 ↗ “Deep neuromuscular block using high dose rocuronium and 8 mmHg pneumoperitoneum” NCT03576118 ↗ “Standard neuromuscular block provided by rocuronium to TOF-count 1-2.” NCT02513693 ↗ “0.6 mg/kg rocuronium was administered to facilitate intubation.” NCT06958913 ↗ “Cisatracurium 0.2mg/kg or alternatively Rocuronium 0.6-1.2mg/kg” NCT04894864 ↗ “fentanyl (1-2 mcg/kg) and rocuronium (0.1mg/kg) and maintained” NCT01566838 ↗ “intravenous rocuronium after induction of general anesthesia” PMID 33537703 ↗ Jun 2021 “Neuromuscular blockade will be performed using rocuronium.” NCT04768400 ↗ “neuromuscular block w/succinylcholine and/or rocuronium” NCT03448068 ↗ “1.2 mg/kg rocuronium once IV access is established” NCT03408340 ↗ “Group I (n = 58) received rocuronium 0.6 mg/kg.” PMID 40542414 ↗ Jun 2025 “esketamine 0.5 mg kg-1, rocuronium 0.6-1mg kg-1” NCT06493396 ↗ “Using rocuronium and reversal with sugammadex” NCT02648503 ↗ “Cisatracurium or alternatively Rocuronium” NCT05172739 ↗ “* Rocuronium for neuromuscular blockade,” NCT07337135 ↗ “Rocuronium 0.3 - 0.9mg/kg intravenously” NCT01511627 ↗ “Pentothal 4mg/kg Rocuronium 0.6 mg/kg” NCT01518608 ↗ “rocuronium (0.4 \~ 0.6 mg / kg)” NCT04063046 ↗ “Muscle relaxant (rocuronium)” NCT03299621 ↗ “Rocuronium and Sugammadex” NCT06553066 ↗ “Rocuronium 1 mg/kg i.v.” NCT02902055 ↗ “rocuronium 0.6-1mg kg-1” NCT06305221 ↗ “rocuronium 0.6mg/kg iv” NCT06120439 ↗ “0,9-1 mg/kg Rocuronium” NCT07568938 ↗ “Rocuronium 0.9mg/kg” NCT01474252 ↗ “Rocuronium” NCT04512313 ↗ “ROCURONIUM” NCT02004015 ↗ |
| Known as | Bromure de rocuronium | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201244 ↗ |
| Known as | Bromuro de rocuronio | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201244 ↗ |
| Known as | Esmeron | “Drug: Rocuronium Intravenous use: 0.3 mg/kg before intubation and 0,7 mg after intubation followed by infusion with 0,3-0,4 mg/kg/h Other Name: Esmeron” NCT01722097 ↗8“During the ablation performed, the patient will be under the influence of a muscle relaxant from the non-depolarising group (rocuronium, Esmeron®).” NCT06707532 ↗ “In this case the use of another neuromuscular blockade, Rocuronium (ESMERON), is an alternative solution.” NCT03960801 ↗ “rocuronium bromide (Zemuron®, Esmeron®)” NCT01564576 ↗ “0.6 mg/kg Rocuronium bromide (esmeron)” NCT06399445 ↗ “Rocuronium (Esmeron):” NCT01651572 ↗ |
| Known as | Org 9426 | “Rocuronium bromide (Org 9426)” NCT00984633 ↗ |
| Known as | ROC | “This study aims to evaluate the influence of age and sepsis on in vivo activity of OATP1A2 using rocuronium (ROC) as a probe and evaluating the pharmacokinetics and...” NCT02399397 ↗ |
| Known as | Rocnium | “Continuous Rocuronium (Rocnium®, Hanlim Pharm. Co., Ltd., South Korea) infusion during surgery” NCT03871387 ↗ |
| Known as | rocunium | “Deep neuromuscular block with 'rocunium®'” NCT03937440 ↗ |
| Known as | Rocuronbromid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00527332 ↗ |
| Known as | rocuronium bromide | “BACKGROUND: Succinylcholine remains the muscle relaxant of choice for rapid sequence induction (RSI) but has many adverse effects. High-dose rocuronium bromide may be an...” PMID 33337797 ↗ Dec 202132“Induction of anesthesia will be the same for all patients and consist of intravenous anesthetic propofol (2-3 mg/kg), opioid analgesic fentanyl (1-1.5 mcg/kg), and muscle...” NCT05958589 ↗ “To achieve NMB, participants received steroidal NMBA Rocuronium Bromide or Vecuronium Bromide administered via i.v. infusion and dosed according to participant ABW.” NCT03346070 ↗ “participants received steroidal NMBA Rocuronium Bromide administered via IV infusion and dosed according to participant body weight.” NCT03346057 ↗ “Propofol, Atracurium Besilate or Cisatracurium besylate or Rocuronium Bromide” NCT04553536 ↗ “rocuronium bromide (Zemuron®, Esmeron®)” NCT01564576 ↗ “Rocuronium Bromide” NCT05687253 ↗ “Rocuronium bromide” NCT04760912 ↗ “Rocuronium bromide” NCT01142635 ↗ |
| Known as | Rocuronium bromide: Zemuron | “Rocuronium bromide: Zemuron” NCT01450813 ↗ |
| Known as | Rocuronium cation | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201244 ↗ |
| Known as | Rocuronium Injectable Solution | “Drug: Rocuronium Injectable Solution” NCT02953210 ↗ |
| Known as | Rocuronium ion | ChEMBL registry synonym — accepted as the source's own label CHEMBL1201244 ↗ |
| Known as | Rocuronium, Esmeron | “Rocuronium, Esmeron” NCT02794714 ↗1“rocuronium: Esmeron” NCT01748643 ↗ |
| Known as | Zemuron | “Rocuronium: Zemuron. Sugammadex: Bridion. Succinylcholine: Suxamethonium” NCT03532178 ↗ |
| Known as | Zemuron Injection (rocuronium bromide) | “Zemuron® Injection (rocuronium bromide)” NCT00751179 ↗1“Zemuron® Injection (rocuronium bromide)” NCT01728584 ↗ |
| Action | Inhibit | “By binding free rocuronium, less rocuronium becomes available at the neuromuscular junction to bind to the muscarine receptor. Non-depolarizing neuromuscular blocking agents...” NCT01631149 ↗ |
| Modality | Other / unclassified | “two commonly used neuromuscular blocking agents (succinylcholine and rocuronium)” NCT01441960 ↗ |
| Route | Intravenous | “A single IV Zemuron bolus dose of 0.45 mg/kg prior to intubation.” NCT00124722 ↗ |